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AGE-ASSOCIATED PERIODONTAL BONE LOSS IN NORMAL AND TLR2- OR 
MYD88-DEFICIENT MICE 
Paul A. Ciero 
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Age-related alterations in innate immunity are poorly understood. The 
identification of those mechanisms, which are dysfunctional in old age, will shed 
light on potential therapeutic strategies for chronic inflammatory diseases 
prevalent in the elderly, such as periodontitis. Mice naturally develop chronic 
periodontitis as a function of age, which is characterized by periodontal bone 
loss. TLR2, a pattern-recognition receptor of leukocytes which mediates 
inflammatory responses in the periodontium, was expressed at higher levels in 
the gingivae of old mice (~18 months) compared with young mice (8 to 10 
weeks). MyD88 is a signaling adaptor protein for TLR2 and other TLRs. We thus 
hypothesized that age-associated periodontal bone loss may be mediated 
through TLR2 and MyD88 and tested this hypothesis in appropriate gene knock-
out mice. Periodontal bone levels were measured as the distance from the 
cementoenamel junction to the alveolar bone crest. Aged TLRZ1- and MyD88-1-
v 
mice developed less periodontal bone loss compared to age-matched wild-type 
mice. These results indicate that TLR2 and its adaptor MyD88 contribute to 
periodontal bone loss in aged mice, implicating these molecules as potential 
targets for drug therapies in the treatment of periodontitis. 
vi 
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BROAD PROBLEM: PERIODONTITIS AND AGE 
Periodontitis is a chronic inflammatory disease that leads to destruction of 
the tissues supporting the teeth. It is the leading cause of tooth loss in adults, 
and one of the most common infection-driven chronic disorders in humans, 
afflicting about 30% of the adult population (Oliver et aI., 1998). In addition, it is 
associated with other conditions including, but not limited to, cardiovascular 
diseases, type 2 diabetes, adverse pregnancy outcomes, respiratory diseases, 
and rheumatoid arthritis (Cullinan et aI., 2009). 
Periodontitis is one of several age-associated diseases. Epidemiologic 
studies have revealed that the prevalence and severity of periodontitis increase 
with age (Oliver et aI., 1998; van der Velden, 1991). Furthermore, the elderly 
population is increasing, making age-associated diseases a high priority for 
researchers (Dounis et aI., 2010; Winker and DeAngelis, 2010). 
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ETIOLOGY AND PATHOGENESIS OF PERIODONTITIS 
In terms of etiology, periodontitis is an infectious disease caused by select 
species of the mouth's indigenous microbiota. These bacteria exist in a highly 
organized plaque biofilm on the tooth surface. The quantitative and qualitative 
composition of the biofilm are of etiologic importance, both of which change as 
disease progresses. Its composition in periodontal health is generally 
characterized by gram-positive facultative anaerobes, while that in disease is 
generally characterized by a shift to gram-negative anaerobes (Socransky and 
Haffajee, 2005). While at least 800 bacterial species exist in the biofilm (Filoche 
et aI., 2010), a relatively small number are believed to be the etiologic agents of 
periodontitis. Those which are believed to play prominent roles include 
Porphyromonas gingivalis, Treponema dentico/a, Prevotella in termedia , 
Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and 
Fusobacterium nuc/eatum (Filoche et aI., 2010; Socransky and Haffajee, 2005). 
Furthermore, the presence of certain periodontal pathogens in combination with 
others is believed to provide a synergy that increases their pathogenicity (Kinane 
and Hajishengallis, 2009). 
The extension of the biofilm into the gingival sulcus begins the series of 
events that mediate periodontal disease. In reaction to the presence of 
pathogens and their metabolic products in the gingival sulcus, host cells including 
neutrophils, epithelial cells and resident macrophages will Signal to initiate the 
inflammatory response. This results in the influx of inflammatory infiltrate from the 
gingival plexus of blood vessels into the gingival sulcus via the junctional 
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epithelium, subjacent to the sulcus. The most abundant cellular component of 
this fluid is neutrophils, however also present are mononuclear phagocytes and 
lymphocytes, as well as complement components (Delima and Van Dyke, 2003). 
While the pathogenesis of periodontal disease is complex and still largely 
undiscovered, it is generally accepted that the chronic nature of the host 
inflammatory response is the main factor in causing tissue damage, rather than 
the direct effects from the pathogens themselves. This is a result of the various 
methods these pathogens have developed in order to survive in this 
environment. 
Neutrophils will attempt to phagocytose the bacteria of the advancing 
plaque front, then utilize their intracellular killing mechanisms. Phagocytosis may 
be enhanced by pathogens opsonized by antibodies or complement fragments. 
However, some periodontal pathogens have developed ways to resist 
phagocytosis using virulence factors such as polysaccharide capsules, or avoid 
phagocytes altogether by gaining entry into host cells (Dennison and Van Dyke, 
1997). 
Another method of fighting periodontal pathogens is extracellularly, via 
neutrophil degranulation, which is utilized in the presence of large quantities of 
bacteria in the gingival sulcus. When neutrophils degranulate, they release 
granular enzymes such as collagenase, elastase, and gelatinase, as well as 
superoxide and oxygen radicals, and nitric oxides. These products do not 
discriminate between the bacteria and the host tissues. Thus, periodontal tissue 
destruction will result from prolonged exposure (Lee et aI., 1995). 
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A major characteristic of periodontitis is alveolar bone loss. The field which 
studies the interactions of the immune system and bone metabolism is called 
osteoimmunology. In periodontitis, chronic inflammation will produce bone-
resorptive cytokines, notably TNFa and IL-113. TNFa can directly stimulate 
osteoclast formation, thereby inducing bone resorption, and also indirectly by 
stimulating RANKL production (Graves et aL, 2011). IL-113 can also induce 
osteoclastogenesis both directly and indirectly through RANKL (Lorenzo et aL, 
2008). The location of the pathogens and the duration of their persistence 
determine clinical outcomes, and when the bacterial insult is deeper in the 
periodontal pocket, in approximation to the alveolar bone for prolonged periods, 
the result is alveolar bone loss (Graves et aL, 2011). 
Adaptive immunity is also likely to playa role in periodontitis. The nature 
of the CD4+ T-cell response may be a critical factor in determining disease 
progression (Teng, 2003). Cytokines produced may favor a Th1- or Th2-biased 
response, and studies have shown that Th2 responses are associated with 
progressive lesions, while Th1 responses are associated with early stable lesions 
(Gemmell et aL, 2002; Gemmell and Seymour, 2004). In addition, the Th1-
associated cytokines IL-12 and IFNy are shown to inhibit osteoclastogenesis 
(Gowen and Mundy, 1986; Gowen et aL, 1986; Horwood et aL, 2001). However, 
there are limitations in the Th1ITh2 paradigm for explaining periodontal disease 
pathogenesis, which must be re-examined in the context of the more recently 
discovered Th17 cells, which have been shown to promote osteoclastogenesis, 
but also to offer protective effects (Gaffen and Hajishengallis, 2008). 
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THE AGING INNATE IMMUNE SYSTEM 
As mentioned, the prevalence and severity of periodontitis increase with 
age (Oliver et aI., 1998; van der Velden, 1991). Furthermore, this is likely due to 
an altered immune system rather than simply a cumulative effect (Fransson et 
aI., 1996). Therefore, research has sought to define which aspects of the immune 
system become dysregulated in order to develop therapeutic strategies to 
counteract age-associated diseases. 
The immune system as a whole is known to dysfunction with age, a 
phenomenon that has been termed, "immunosenescence." Age-associated 
defects have been noted in all types of immune cells, impacting on their 
numbers, function, or both (Gomez et aI., 2008). This inhibits the body's ability to 
recover from infections and injuries; thus, the elderly are more susceptible to 
chronic inflammatory diseases. 
It is well-known that aging is associated with a decline in the functions of 
acquired immunity. For example, age-associated decreases in the production of 
na·ive lymphocytes and the maintenance of memory lymphocytes have been 
observed (Nan-ping, 2006). 
However, the effects of aging on the innate immune system are poorly 
understood. This is largely because immunologists underestimated its role in 
shaping the adaptive response, and therefore its overall significance, until 
relatively recently (Fearon, 1997). It is now known that in addition to providing 
initial defense, the innate response controls the adaptive component in a variety 
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of different ways. This includes the ability of Toll-like receptors (TLRs) to 
recognize and respond to pathogens with a fair degree of specificity (Yamamoto 
et aI., 2004). 
Advanced age is associated not only with losses in immune function, but 
with over-activation as well, implying a complex overall dysregulation rather than 
deficiencies alone. The overall increased pro-inflammatory status seen in aged 
humans has been termed "inflamm-aging." Though it is not clear what exactly 
causes this phenomenon, it likely results from some age-associated intrinsic 
defects in the innate immune system, which is responsible for controlling 
inflammation (Franceschi et aI., 2000; Solana et aI., 2006). 
Studies have thus sought to determine age-associated defects in the cells 
of the innate immune system, especially neutrophils and macrophages, which 
play essential roles in inflammatory diseases. Due to conflicting results, there are 
still consensus conclusions to be made in this field, and some reports conclude 
that many functions are maintained (Liang et aI., 2009). Nevertheless, several 
alterations in these cells have been reported. These studies have been recently 
reviewed in detail by Gomez (Gomez et aI., 2008), Hajishengallis (Hajishengallis, 
2010), and Shaw (Shaw et aI., 2010). In summary, circulating neutrophil numbers 
are maintained with age, unlike monocyte/macrophage numbers, which have 
been shown to increase. Functionally, neutrophils and macro phages have both 
been reported to experience impaired chemotaxis, phagocytosis, and reactive 
oxygen species production. Neutrophils have also shown reduced recruitment of 
receptors to membrane lipid rafts, which can have several diverse effects on 
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signaling (Fulop et aI., 2004). The reviews also report altered cytokine 
production, nitric oxide production, antigen presentation, and expression of 
certain receptors involved in inflammation, including the C5aR (Liang et aI., 
2009) in macrophages. Reports have also indicated age-associated defects in 
dendritic cells, natural killer cells, and natural killer T-cells. (Shaw et aI., 2010). 
These types of defects could inhibit the host's ability to control microbial 
infections. For instance, neutrophils from an aged individual may fail to contain a 
periodontal infection due to its intrinsically impaired antimicrobial abilities, which 
would result in the recruitment of even more neutrophils with impaired functions. 
Thus, the environment would become chronically inflamed, and the eventual 
release of toxic substances from these neutrophils could cause tissue damage. 
(Hajishengallis, 2010). 
While it is important to continue studying age-associated intrinsic defects 
in immune cells, this research provides only limited insights into ways to 
counteract age-related diseases. The ways in which these defects influence the 
host response and disease progression are more complex. Immune cells interact 
with their tissue microenvironment, which is also susceptible to age-associated 
changes. In fact, age-associated changes in stromal cell function and imbalances 
in cytokines and hormones have been reported to affect the immune response 
(Stout and Suttles, 2005). 
Thus, age-related influences on innate immunity are tissue-specific and 
disease-specific. Experiments done in vitro cannot accurately replicate this, and 
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in vivo experiments may provide better insight into ways we may counteract age-
related factors contributing to periodontitis because they take into account both 
intrinsic and extrinsic factors. 
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INSIGHTS FROM IN VIVO STUDIES 
Animal models serve as an essential tool for testing hypotheses that, due 
to ethical considerations, cannot be tested in humans. The mouse model has 
been a successful tool in studying infection-driven inflammatory diseases 
including periodontitis, owing to the substantial background information on their 
immune systems and the availability of gene knockout mice, as well as their 
affordability relative to other animal models (Graves et aI., 2008). This allows us 
to test hypotheses in vivo regarding processes taking place in the periodontium 
including bacterial colonization, host-bacteria interactions, and clinical 
manifestations of disease such as loss of connective tissue attachment and bone 
resorption (Graves et aI., 2008). 
Periodontitis is typically induced in mice using oral gavage with human 
periodontal pathogens such as Porphyromonas gingivalis, Tannerella forsythia, 
and Aggregatibacter actinomycetemcomitans, which is evidenced by alveolar 
bone loss (Baker et aI., 2000; Garlet et aI., 2006; Hajishengallis et aI., 2007; 
Sharma et aI., 2005). While young sham-infected mice typically do not develop 
periodontitis, studies showed that young mice with P/E-selectin deficiency 
(Niederman et aI., 2001) or impaired neutrophils (Beertsen et aI., 2008) did in fact 
develop early-onset periodontitis. This indicated that the experimental mice 
contained potential periodontal pathogens despite claims by animal vendors that 
their mice are pathogen-free. Indeed, these studies showed that periodontal 
inflammation and bone loss in these mice were prevented by antibiotic treatment 
(Beertsen et aI., 2008; Niederman et aI., 2001). 
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Due to these revelations and the association of old age with periodontitis, 
it was suspected that mice could develop naturally-induced periodontitis as a 
function of age, without oral infections with human periodontal pathogens. 
Indeed, mice aged 18 months showed significant alveolar bone loss compared 
with young mice at 8-10 weeks (Figure 1) (Liang et aI., 2010). 
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Figure 1: Periodontal bone loss in mice as a function of age. Young BALB/c 
mice (8-10 weeks of age) and old (~18 months) and mice of intermediate ages 
(6,9,12 and 14 months) were used to determine their periodontal bone levels. No 
oral gavage was administered in these mice. The distance (in mm) from the 
cementoenamel junction (CEJ) to the alveolar bone crest (ABC) was measured 
in 14 predetermined maxillary buccal sites, and the readings were totaled for 
each mouse. The data are means ± SD (n = 5 mice). Liang et ai, J. Periodont. 
Res. (2010). 
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Consistently, the gingivae of these old mice displayed increased 
expression of IL-1~, TNF-a, and IL-17A, which are mediators of inflammation and 
bone loss (Liang et aI., 2010). Furthermore, age-associated expressions of 
inflammatory mediators were not observed in the spleens of these mice, 
indicating the periodontal environment as the influential factor in these 
observations, rather than global age-dependent changes (Liang et aI., 2010). 
This aging model of periodontitis allows us to study mechanisms in the pathology 
of chronic periodontitis, and the current investigation aims to use this model 
accordingly. 
In addition to the expression of aforementioned inflammatory mediators 
(lL-1~, TNF-a, and IL-17A), Liang et al. also investigated the expression of 
innate immune receptors in the gingivae of the young and old mice. Those innate 
immune receptors which were upregulated in the gingivae of old mice compared 
with young included the Toll-Like Receptor 2 (TLR2) and its functionally 
















Figure 2: Relative expression of innate immune receptors in the gingivae of 
young and old mice. Quantitative real-time PCR (qPCR) was used to determine 
gingival mRNA expression levels for the indicated receptors (normalized against 
GAPDH mRNA levels). The gingivae used were excised from young (8-10 wk of 
age) and old BALB/c mice (~ 18 mo of age). Results are shown as fold induction 
relative to young. Each data point represents the mean ± SD of 10 separate 
expression values, corresponding to qPCR analysis of total gingival RNA from 
individual mice. A minimum of 2-fold difference was a requirement for further 
testing of statistical significance. Asterisks indicate statistically significant 
differences (p < 0.05) between old and young mice. TLR2 mRNA expression was 
increased in the old mice relative to the young. Liang et ai, J. Periodont. Res. 
(2010). 
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These findings imply the likelihood that TLR2 signaling is contributing to 
age-associated periodontal inflammation. A large body of work consistently 
indicates TLR2 as being a key receptor in human periodontitis, which is outlined 
in the next section. 
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THE ROLE OF TLR2 IN PERIODONTITIS PATHOLOGY 
The Toll-like receptors (TLRs) are a family of pattern recognition receptors 
that play critical roles in the innate immune response to microbes. They are type 
1 integral membrane glycoproteins expressed on various immune cells including 
macrophages, dendritic cells, neutrophils, B-cells, and natural killer cells, as well 
as non-immune cells such as mucosal epithelial cells, endothelial cells, and 
fibroblast cells. They recognize and respond to pathogen-associated molecular 
patterns (PAMPs), which are molecules present on microbes but absent in 
mammalian cells, allowing the host's initial distinction between "self' from "non-
self'. TLRs contain an extracellular leucine-rich repeat domain, a transmembrane 
domain, and a cytoplasmic TIR (Toli/interleukin-1 receptor) domain, which is 
essential for signaling. In response to ligand binding by TLRs, the TIR domain 
initiates signaling cascades which ultimately result in the activation of 
transcription factors such as NFKB, AP-1, IRF-3, and IRF-7. The NFKB and AP-1 
transcription factors promote the expression of genes encoding molecules of the 
innate immune response such as inflammatory cytokines, chemokines, and 
endothelial adhesion molecules. On the other hand, IRF-3 and IRF-7 primarily 
promote the production of type 1 interferons. 
TLRs are classified into groups based on the types of ligands they 
recognize, and they are differentially located in the cell. There are 11 known 
TLRs expressed in humans and 13 in mice (Kawai and Akira, 2007). TLR1, 
TLR2, TLR4, TLR5, and TLR6 appear on the plasma membrane and TLR3, 
TLR7, TLR8, and TLR9 are expressed on endosomes. The capacity of TLRs to 
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recognize a wide range of ligands is enhanced by their ability to homodimerize, 
heterodimerize, and to integrate coreceptors. They may recognize lipids, sugars, 
proteins, derivatives of these molecules, and nucleic acids (Kumar et aI., 2009a). 
TLRs playa key role in the periodontal immune response, as evidenced 
by the infiltration of TLR-expressing inflammatory cells and the increased TLR 
expression in diseased gingivae compared with healthy gingivae (Mori et aI., 
2003; Ren et aI., 2005). 
Research is actively identifying TLR ligands, and conflicting results delay 
consensus conclusions. TLR2 and TLR4, however, have been identified as the 
principal receptors for bacterial cell wall components. A large body of work 
focuses on the roles of these two receptors in periodontal disease (Burns et aI., 
2006; Folwaczny et aI., 2004; Hajishengallis et aI., 2009; Hou et aI., 2000; Kikkert 
et aI., 2007; Mori et aI., 2003; Sun et aI., 2010; Yoshioka et aI., 2008). 
TLR4 functions as a homodimer and is the most characterized of all TLRs 
(McCoy and O'Neill, 2008). It functions in association with the accessory 
molecules LBP (LPS binding protein), CD14, and MD-2 (Akashi-Takamura and 
Miyake, 2008; Shimazu et aI., 1999; Wright et aI., 1989; Wright et aI., 1990). 
Among its ligands are lipopolysaccharide (LPS) from Gram-negative bacteria 
(Kumar et aI., 2009a; Takeuchi et aI., 1999). It has been shown that TLR4-1- mice 
are protected from bone loss following a mixed anaerobic infection (Hou et aI., 
2000), implying its involvement in periodontitis. 
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TLR2 can recognize an array structurally diverse PAMPs, including 
proteins, lipoproteins, lipopeptides, glycolipids, polysaccharides, and even 
complete pathogens (Kumar et aI., 2009a). To name some ligands from recent 
reviews, TLR2 recognizes peptidoglycan, L TA, LPS of Porphyromonas gingivalis, 
LPS of Leptospira, mycobacteriallipoarabinomannan, glycosylphosphatidyl 
inosital mucin from Trypanosoma, hemagglutinin from the measles virus, fungal 
zymosan, and phospholipomannan from Candida (Brown et aI., 2010; Kawai and 
Akira, 2007; Kumar et aI., 2009a). The diversity of TLR2 recognition owes 
partially to its ability to heterodimerize with TLR1 or TLR6 to recognize triacyl or 
diacyllipoproteins, respectively (Takeuchi et aI., 2001; Takeuchi et aI., 2002) as 
well as its associations with accessory molecules CD14 and CD36 (Akashi-
Takamura and Miyake, 2008). It has also been shown to dimerize with TLR10, 
though the ligands for this heterodimer are unknown (Hasan et aI., 2005). TLR2 
has been reported to recognize the broadest range of bacterial PAMPs, and its 
precise ligands are continually being discovered and debated (Zahringer et aI., 
2008). 
Regarding the prevalence of TLR2 activation in the periodontium as 
opposed to TLR4, recent evidence implicates TLR2 as the primary TLR 
stimulated by Gram-negative periodontal bacteria. Kikkert et al. demonstrated 
that sonicates of the gram-negative periodontal pathogens P. gingiva/is, P. 
in termedia , F. nucleatum,and T. forsenthis exclusively stimulated TLR2 while A. 
actinomycetemcomitans stimulated both TLR2 and TLR4 (Kikkert et aI., 2007). 
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Studies have also shown that T. dentico/a activates TLR2, rather than TLR4 
(Asai et aI., 2003; Nussbaum et aI., 2009; Ruby et aI., 2007). 
Studies regarding P. gingiva lis are especially significant. This pathogen 
successfully subverts the immune response (Hajishengallis, 2009) en route to 
triggering community-wide changes in the biofilm disruptive to host-microbial 
homeostasis; thus, this "keystone species" plays an essential role in 
inflammatory bone loss (Hajishengallis et aI., 2011). Studies have indicated that 
P. gingiva lis stimulates both TLR2 and TLR4 through various components, 
including its LPS and fimbriae, but also antagonizes TLR4 (Asai et aI., 2001; 
Darveau et aI., 2002; Hajishengallis et aI., 2004; Teng, 2006). However, the 
exact ligands are still a matter of debate. Nevertheless, Burns et al. 
demonstrated that TLR2 is responsible for the innate response to P. gingiva lis 
and that TLR2 deficiency, but not TLR4 deficiency, attenuates alveolar bone 
resorption in vivo (Burns et aI., 2006). 
Additionally, Ukai et al. reported that macrophage-elicited 
osteoclastogenesis in response to bacterial stimulation requires TLR2-dependent 
TNFa production (Ukai et aI., 2008), further implying TLR2 activation as a 
principle PRR in periodontal bone loss. 
In addition to inflammatory signaling, TLRs likely impact periodontitis in 
other ways. Though they are not phagocytic receptors, studies have revealed 
their importance for each stage of phagocytosis (McCoy and O'Neill, 2008; 
Underhill and Gantner, 2004). In addition, TLR signaling plays crucial roles in 
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antigen processing and presentation (McCoy and O'Neill, 2008). They can 
promote B7 costimulatory molecules as well as MHC class II molecules (Iwasaki 
and Medzhitov, 2004). 
TLR-mediated signaling by antigen-presenting cells, especially dendritic 
cells, can also modulate the adaptive response through its induction of 
immunomodulatory cytokines (Iwasaki and Medzhitov, 2004). As mentioned 
previously, studies have shown that in periodontitis, Th2 responses are 
associated with progressive lesions, while Th1 responses are associated with 
early stable lesions (Gemmell et aI., 2002; Gemmell and Seymour, 2004). TLR2 
has relevance to this pattern; studies indicate that TLR4 stimulation promotes a 
Th1 response through production of IL-12p70, IFNy, and other Th1-associated 
molecules whereas TLR2 stimulation tends to promote a Th2 response, due in 
part to its failure to induce the IL-12p35 subunit (Goriely et aI., 2008; Hirschfeld et 
aI., 2001; Re and Strom inger, 2001). Therefore, one can infer that the periodontal 
bacteria dictate the nature of the adaptive response, and therefore the 
progression of disease, through their specificities as TLR agonists. Thus, TLR2 
can contribute to disease progression through its shaping of the adaptive 
response. 
TLR2 is also involved in periodontal disease pathogenesis through its 
interactions with the complement system, which is also activated in periodontitis 
(Delima and Van Dyke, 2003). The signaling pathways of complement 
components and TLRs can engage in crosstalk, an important immune function 
under normal conditions. Certain pathogens in turn have developed methods to 
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exploit these crosstalk pathways to promote their own survival. TLR2 is utilized in 
this sense by periodontal pathogens. 
TLR2 engages in crosstalk with C5aR, which was also differentially 
upregulated in the gingivae of old mice (Figure 2) (Liang et aI., 2010). 
Furthermore, C5aR-deficient mice are protected from age-associated periodontal 
bone loss, implicating C5aR in age-associated periodontitis (Liang et aI., 2011). 
TLR2-C5aR crosstalk is exploited by P. gingiva lis , which not only activates TLR2, 
but cleaves C5 through the action of its gingipains, thereby inducing the release 
of excessive amounts of the anaphylatoxin C5a, the ligand for C5aR (Wingrove 
et aI., 1992). This crosstalk exploitation can promote the survival of P. gingiva/is 
in more than one way. First, TLR2-C5aR crosstalk in macro phages will cripple 
cellular immunity through inhibition of TLR2-dependent IL-12p70 production. The 
MEK-ERK1/2 pathway is implicated in this C5aR-mediated regulatory pathway, 
which is selective for IL-12p70; this crosstalk also produces excessive pro-
inflammatory and bone-resorptive cytokines such as IL-1~, IL-6, and TNF-a 
(Liang et aI., 2011). Secondly, TLR2-C5aR crosstalk can increase cyclic 
adenosine monophosphate (cAMP) concentrations in macrophages, which 
promotes a cAMP-dependent protein kinase A (PKA) signaling pathway that 
ultimately prevents iNOS production (Wang et aI., 2010). 
Furthermore, activation of TLR2-CXCR4 crosstalk by P. gingivalis inhibits 
iNOS production in the same cAMP-dependent manner as TLR2-C5aR crosstalk 
does (Hajishengallis et aI., 2008), and these two crosstalk pathways can even act 
synergistically (Wang et aI., 2010). 
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Finally, P. gingiva lis and Mycobacterium tuberculosis (and potentially 
other pathogens) exploit TLR2-complement receptor 3 (CR3) interactions for 
intracellular entry, inhibition of IL-12p70, and enhanced persistence in 
macro phages (Hajishengallis et aI., 2007; Hajishengallis, 2009; Wang et aI., 
2007). CD11 band CD18, which heterodimerize to form CR3 (CD11 b/CD18), 
were also differentially upregulated in the gingivae of old mice (Figure 3), 
suggesting the possibility that mouse periodontal bacteria are exploiting this 
pathway (Liang et aI., 2010). 
Though P. gingiva lis is the pathogen of interest in these studies, and TLR2 
the receptor of interest, it is likely that other oral pathogens exploit these 
crosstalk mechanisms in periodontitis, or similar, yet undiscovered ones to 
promote their virulence, given the novelty and importance of this specific field 
(Hajishengallis and Lambris, 2011). 
Despite the lack of knowledge regarding the bacterial profile in the 
periodontium of the aged, diseased mice studied by Liang et al. (Liang et aI., 
2010), the differential up-regulation of TLR2 in comparison to other PRRs, 
including TLR4 (Figure 2), in the gingivae of the aged mice is consistent with the 
conclusion that TLR2 signaling is a critical contributor in periodontitis pathology. 
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THE ROLE OF MYD88 IN TLR2- AND TLR4- SIGNALING 
MyD88 plays an essential role in TLR2-mediated inflammatory signaling. It 
is one of five adaptor proteins utilized in TLR signaling, in addition to MyD88-
adaptor-like (MAL; also known as TIRAP), TIR-domain-containing adapter 
protein inducing IFN~ (TRIF), TRIF-related adaptor molecule (TRAM), and sterile 
a- and armadillo-motif-containing protein (SARM). Different TLR groups use 
different combinations of these adapters, gifting the TLR-mediated response with 
even more specificity (O'Neill and Bowie, 2007). 
Though TLR2 and TLR4 share many downstream signaling pathways 
inducing some of the same innate cytokines such as IL-1 and TNFa, there are 
also differences in their signaling capacities. TLR2 and TLR4 both use MAL in 
addition to MyD88; MAL links the TLRs to MyD88 (though some TLRs do not 
require MAL for this purpose). In addition, TLR4 utilizes TRIF and TRAM in an 
MyD88-independent pathway, with TRAM linking TLR4 with TRIF. Thus, TLR 
signaling can be broadly categorized into two pathways: the MyD88-dependent 
pathway, which is utilized by all TLRs except TLR3, and the MyD88-independent 
pathway, or TRIF-dependent pathway, which is utilized exclusively by TLR3 and 
TLR4 (Brown et aI., 2010; Kumar et aI., 2009a; O'Neill and Bowie, 2007). 
In the MyD88-dependent pathway, a cascade of kinases involving 
members of the IRAK family, TRAF-6, and TAK1 are activated. This then initiates 
the MAP kinases and IkB kinases, which activate AP-1 and NFKB, respectively to 
promote the transcription of pro-inflammatory cytokines including TNFa and IL-1~ 
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(Brown et aI., 2010). My088 is essential for inflammatory signaling; studies have 
shown unresponsiveness to ligands for both TLR2 and TLR4 in MyD8£r1- mice 
(Kawai et aI., 1999; O'Neill and Bowie, 2007; Takeuchi et aI., 2000). 
In the My088-independent pathway, a cascade of kinases involving 
TRAF-3, TBK1 and IKKi ultimately activates the transcription factor IRF-3, which 
primarily promotes the production of type I interferons. However, this pathway 
can also promote inflammatory cytokine production because TRIF can activate 
TAK1. However, this occurs with delayed kinetics in comparison with that of the 
My088-dependent pathway (Brown et aI., 2010; Kawai et aI., 1999; Kumar et aI., 
2009b; Yamamoto et aI., 2003). 
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Figure 3. TLR adaptor molecules and signaling pathways. Signaling 
specificity of a given TLR can be imparted via the interaction of its TIR domain 
with MyD88, TIRAP, TRIF, or TRAM. All TLRs except TLR3 utilize MyD88 for the 
production of inflammatory cytokines. TLR2 and TLR4 recruit MALITIRAP and 
MyD88 to their TIR domain for activation of NF-KB and MAPKs that regulate 
inflammatory cytokine production. TLR4 can signal independently of MyD88 via 
the recruitment of TRAM and TRIF that activate IRF3 for the production of type I 
IFNs and delayed activation of MAPKs and NF-KB activity through TAK1. Brown 
et al., J. Dent. Res., (2010). 
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HYPOTHESIS 
Mice develop naturally occurring periodontitis as a function of age. TLR2 
can induce pro-inflammatory signals and was found to be differentially 
upregulated in the gingivae of aged mice as compared to young controls. MyD88 
is a major signaling adaptor acting downstream of TLR2. Therefore, I 
hypothesized that TLRZ/' and MyD88.f- mice would be protected from age-
associated periodontal bone loss. This would implicate these molecules in 




MATERIALS AND METHODS 
MICE 
C57BLl6 wild-type, TLRZ1-, and MyD8W-, and BALB/c wild-type mice were 
obtained from The Jackson Laboratory. The TLRZ1- mice were originally C57BLl6 
and we backcrossed them for nine generations onto a BALB/c genetic 
background before their use in these studies. Mice were raised to appropriate 
ages under specific-pathogen-free conditions in individually ventilated cages in 
the Barrier Animal Facility of the University of Louisville. All animal procedures 
described in this study were approved by the Institutional Animal Care and Use 
Committee, in compliance with established federal and state policies. 
DETERMINATION OF PERIODONTAL BONE LOSS 
Periodontal bone levels were assessed in defleshed maxillae under a 
dissecting microscope (x40) fitted with a video image marker measurement 
system (VIA-170K; Boeckeler Instruments) standardized for measurements in 
millimeters. Specifically, the distance from the cementoenamel junction (CEJ) to 
the alveolar bone crest (ABC) was measured on 14 predetermined points on the 
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buccal surfaces of the maxillary molars. To calculate relative bone loss (e.g. 
TLRZ1- mice vs. wild-type controls, or old mice vs. young controls), the 14-site 
total CEJ-ABC distance for each mouse was subtracted from the mean CEJ-ABC 
distance of control mice. The results were expressed in mm and negative values 
indicated bone loss relative to controls. 
ORAL BACTERIA SAMPLING 
To assess the oral microbial burden, the murine oral cavity was sampled 
for 15 seconds using sterile paperpoints in contact with the gumlines. Serial 
dilutions of the paperpoint extracts were inoculated on GAM blood agar plates 
and grown anaerobically at 3rC for one week for CFU determination. 
QUANTITATIVE REAL-TIME PCR 
Immediately upon sacrificing, gingival tissue was excised from around the 
maxillary molars. Total RNA was extracted using the PerfectPure RNA cell kit (5 
Prime, Fisher) and quantified by spectrometry (Nanodrop) at 260 and 280 nm. 
The RNA was reverse-transcribed using the High-Capacity cDNA Archive kit 
(Applied Biosystems) and quantitative real-time PCR was performed using the 
ABI 7500 Fast System, according to the manufacturer's protocol (Applied 
Biosystems). TaqMan probes, sense primers, antisense primers for expression of 
genes examined in this study (Figures 7,11), or a housekeeping gene (GAPDH), 
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were purchased from Applied Biosystems. Samples were denatured for 23 
seconds at 95°C and annealed and extended at 60°C for 30 seconds following 
the manufacturer's protocol (Applied Biosystems) for a total of 40 cycles. Target 
genes vs. GAPDH were calculated as fold change using the relative quantitation 
formula, zMCt. 
STATISTICAL ANALYSIS 
Data were evaluated by analysis of variance and the Dunnett multiple-
comparison test using the InStat program (GraphPad Software, San Diego, CA). 
Where appropriate (comparison of two groups only), two-tailed t tests were 




TLRZ1- MICE DEVELOP LESS AGE-ASSOCIATED BONE LOSS THAN WILD-
TYPE CONTROLS 
Mice develop naturally occurring periodontitis as a function of age. TLR2 
can induce pro-inflammatory signals and was found to be differentially 
upregulated in the gingivae of aged mice as compared to young controls. 
Therefore, we investigated whether TLR2 deficiency attenuated age-associated 
periodontal bone loss. BALB/c and TLRZ1- mice were raised under specific-
pathogen-free conditions, and then sacrificed at two time points: the young group 
(5 mice per group) at 8 weeks, and the old (16 mice per group) at 18 months. 
Bone levels were measured as the distance from the cemento-enamel junction to 
the alveolar bone crest from 14 predetermined maxillary buccal sites. The 
BALB/c Wild-type and TLRZ1- mice had similar bone levels in their youth at 8 
weeks. Both groups showed greater bone loss when aged. However, TLRZ1-
mice showed less age-associated change compared to the wild-types (Figure 4). 
Thus, TLRZ1- mice experience less age-associated periodontal bone loss relative 
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Figure 4. Age-associated periodontal bone loss in Normal and TLRZ1• mice. 
The total distance (mm) from the cementoenamel junction (CEJ) to the alveolar 
bone crest (ABC) from 14 predetermined maxillary buccal sites in each sample 
was measured on 5 young (8 week-old) and 16 old (18 month-old) mice for each 
group. Greater CEJ-ABC distances indicate greater bone loss. (Top) Each point 
corresponds to the sum of these distances for each sample. Old TLRZ1- mice 
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exhibited less (*p < 0.01) bone loss compared with age-matched BALB/c wild-
type mice. (Bottom) The average changes in CEJ-ABC distances from young to 
old mice for BALB/c wild-type and TLRZ1- mice. The TLRZ1- mice showed less (*p 
< 0.01) age-associated change relative to the wild-type controls. Data are means 
± SD (Bottom). 
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Figure 5. Representative images of CEJ-ABC distances in wild-type and 
TLR2-1- mice at 18 months. Representative images of defleshed maxillae 
showing that TLRZ1- mice (right) develop less age-associated bone loss 
compared to BALB/c wild-type controls (left). Periodontal bone levels were 
assessed under a dissecting microscope (x40) fitted with a video image marker 
measurement system (VIA-170K; Boeckeler Instruments) standardized for 
measurements in millimeters. The distance from the cementoenamel junction 
(CEJ) to the alveolar bone crest (ABC) was measured on 14 predetermined 
points on the buccal surfaces of the maxillary molars. 
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ORAL ANAEROBIC BACTERIAL LOAD IS INCREASED IN AGED TLR2-1- MICE 
Inflammation can kill bacteria when operating as intended, but can also 
contribute to their persistence by providing nutrients. We investigated the 
influence of TLR2 deficiency on oral microbial burden to determine the effects of 
the inflammatory response in this respect. To assess the oral microbial burden, 
the murine oral cavity was sampled for 15 seconds using sterile paperpoints in 
contact with the gumlines. Serial dilutions of the paperpoint extracts were 
inoculated on GAM blood agar plates and grown anaerobically at 3rC for one 
week for CFU determination. TLRZ1- mice were less able to clear these bacteria 
from the oral cavity than their BALB/c wild-type controls (Figure 6). 
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Figure 6. Oral anaerobic bacterial load is increased by TLR2 deficiency in 
aged mice. The murine oral cavities of 16 old (18 months) BALB/c wild-type and 
16 old TLRZ1- mice were each sampled for 15 seconds using sterile paperpoints 
in contact with the gumlines. Serial dilutions of the paperpoint extracts were 
inoculated on GAM blood agar plates and grown anaerobically at 3rC for one 
week for CFU determination. The TLRZ1- mice showed greater (p < 0.01) CFU 
than their age-matched wild-type mice. 
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GINGIVAL EXPRESSION OF INNATE INFLAMMATORY MEDIATORS 
INDICATES LESSENED INFLAMMATION IN AGED TLR2-1- MICE 
To determine inflammatory mechanisms of the innate immune system 
influenced by TLR2 deficiency in aged mice, we investigated the expression of 
innate receptors, adapters, and cytokines involved in inflammation in the gingivae 
of the aged (18 months) BALB/c wild-type and TLRZ1- mice. Quantitative real-
time PCR was used to determine gingival mRNA expression levels for the 
indicated receptors (normalized against GAPDH mRNA levels). This data shows 
expression levels in the gingivae of 18-month old TLRZ1- mice relative to their 
wild-type controls (Figure 7). The mRNA expression of inflammatory markers 
was overall reduced in the old TLRZ1- mice compared with their age-matched 
BALB/c wild-type controls. Those molecules of particular interest which were 
expressed at lower levels in the TLRZ1- mice included TLR1, TLR6, CD14, 
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Figure 7. mRNA expressions in the gingivae of old TLR2-/- mice relative to 
wild-type controls. Quantitative real-time PCR was used to determine gingival 
mRNA expression levels for the indicated innate receptors and adapters (Top), 
and inflammatory markers (Bottom). The gingival tissue used was excised from 
around the maxillary molars of aged (18 months) TLRZ/- mice and aged BALB/c 
wild-type mice. Results are shown as fold change of aged TLRZ/- mice relative to 
BALB/c wild-type mice. Each data point represents mean ± SD of 3 separate 
expression values, corresponding to qPCR analysis of total gingival RNA from 
individual mice. 
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MYD88-1- MICE DEVELOP LESS AGE-ASSOCIATED BONE LOSS THAN WILD-
TYPE CONTROLS 
Mice develop naturally occurring periodontitis as a function of age. MyD88 
is a major signaling adaptor acting downstream of TLR2, which was found to be 
differentially upregulated in the gingivae of aged mice as compared to young 
controls. Therefore, we investigated whether MyD88 deficiency attenuated age-
associated periodontal bone loss. C57BLl6 and MyD88-1- mice were raised under 
specific-pathogen-free conditions, and then sacrificed at two time pOints: the 
young group (5 mice per group) at 8 weeks, and the old (9 mice per group) at 18 
months. Bone levels were measured as the distance from the cemento-enamel 
junction to the alveolar bone crest from 14 predetermined maxillary buccal sites. 
The C57BLl6 wild-type and MyD88-1- mice had similar bone levels in their youth 
at 8 weeks. Both groups showed greater bone loss when aged. However, 
MyD88-1- mice showed less age-associated change compared to the wild-types 
(Figure 8). Thus, MyD88-1- mice experience less age-associated periodontal bone 
loss relative to the wild-type controls. 
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Figure 8. Age-associated periodontal bone loss in Normal and MyD88-1-
mice. The total distance (mm) from the cementoenamel junction (CEJ) to the 
alveolar bone crest (ABC) from 14 predetermined maxillary buccal sites in each 
sample was measured on 5 young (8 week-old) and 9 old (18 month-old) mice 
for each group. Greater CEJ-ABC distances indicate greater bone loss. (Top) 
Each point corresponds to the sum of these distances for each sample. Old 
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MyD8a-1- mice exhibited less (*p < 0.01) bone loss compared with age-matched 
C57BLl6 wild-type mice. (Bottom) The average changes in CEJ-ABC distances 
from young to old mice for C57BLl6 wild-type and MyD88-1- mice. The MyD88-1-
mice showed less (*p < 0.01) age-associated change relative to the wild-type 
controls. Data are means ± SO (Bottom). 
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Figure 9. Representative images of CEJ-ABC distances in wild-type and 
MyD88-1- mice at 18 months. Representative images of defleshed maxillae 
showing that MyD88-1- mice (right) develop less age-associated bone loss 
compared to C57BLl6 wild-type controls (left). Periodontal bone levels were 
assessed under a dissecting microscope (x40) fitted with a video image marker 
measurement system (VIA-170K; Boeckeler Instruments) standardized for 
measurements in millimeters. The distance from the cementoenamel junction 
(CEJ) to the alveolar bone crest (ABC) was measured on 14 predetermined 
points on the buccal surfaces of the maxillary molars. 
40 
ORAL ANAEROBIC BACTERIAL LOAD IS DECREASED IN AGED MYDBB-1-
MICE 
Inflammation can kill bacteria when operating as intended, but can also 
contribute to their persistence by providing nutrients. We investigated the 
influence of MyD88 deficiency on oral microbial burden to determine the effects 
of the inflammatory response in this respect. To assess the oral microbial 
burden, the murine oral cavity was sampled for 15 seconds using sterile 
paperpoints in contact with the gumlines. Serial dilutions of the paperpoint 
extracts were inoculated on GAM blood agar plates and grown anaerobically at 
3rC for one week for CFU determination. MyDBErI- mice were able to clear these 
bacteria from the oral cavity more effectively than their C57BLl6 wild-type 
controls (Figure 10). 
41 




::) 75000 • 
u.... • 
U 50000 • •• •• • • 25000 •• * ••• w • 
• •••••• 0 
Wild-type MyD88-'-
Figure 10. Oral anaerobic bacterial load is decreased by MyD88 deficiency 
in aged mice. The murine oral cavities of 12 old (18 months) C57BLl6 wild-type 
and 15 old MyD8a-1- mice were each sampled for 15 seconds using sterile 
paperpoints in contact with the gumlines. Serial dilutions of the paperpoint 
extracts were inoculated on GAM blood agar plates and grown anaerobically at 
3rC for one week for CFU determination. The MyD8a-1- mice showed greater (p 
< 0.01) CFU than their age-matched wild-type mice. 
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GINGIVAL EXPRESSION OF INNATE INFLAMMATORY MEDIATORS 
INDICATES ACTIVATION OF TRIF-DEPENDENT PATHWAY IN AGED 
MYDBa-I- MICE 
To determine inflammatory mechanisms of the innate immune system 
influenced by MyD88 deficiency in aged mice, we investigated the expression of 
innate receptors, adapters, and cytokines involved in inflammation in the gingivae 
of the aged (18 months) C57BLl6 wild-type and MyDBa-I- mice. Quantitative real-
time PCR was used to determine gingival mRNA expression levels for the 
indicated receptors (normalized against GAPDH mRNA levels). This data shows 
expression levels in the gingivae of 18-month old MyDBa-I- mice relative to their 
wild-type controls (Figure 11). Of particular interest was the increased mRNA 
expression of TLR4, TRIF, and IFN~, in the old MyDBa-I- mice compared with 
wild-type controls, which indicate activation of the TRIF-dependent pathway. Also 
of interest were the increased expression of RANKL and the decreased 
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Figure 11. mRNA expressions in the gingivae of old MyD88·/· mice relative 
to wild-type controls. Quantitative real-time PCR was used to determine 
gingival mRNA expression levels for the indicated innate receptors and adapters 
(Top), and inflammatory markers (Bottom). The gingival tissue used was excised 
from around the maxillary molars of aged (18 months) MyD88-/- mice and aged 
C57BLl6 wild-type mice. Results are shown as fold change of aged MyD88-/-
mice relative to C57BLl6 wild-type mice. Each data point represents mean ± SD 
of 3 separate expression values, corresponding to qPCR analysis of total gingival 
RNA from individual mice. 
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CHAPTER IV: 
DISCUSSION AND CONCLUSIONS 
DISCUSSION 
We found that TLRZ1- and MyDBB-1- mice developed less age-associated 
periodontal bone loss compared with wild-type controls (Figures 4,8). Therefore, 
TLR2 and MyD88 must contribute to age-associated periodontal bone loss. We 
were unable to determine which molecule contributes more significantly because 
the TLRZ1- mice were of BALB/c background whereas the MyDBff- mice were of 
C57BLl6 background. The TLRZ1- mice were backcrossed onto a BALB/c genetic 
background to accommodate other projects by our lab. 
Past studies have shown that TLRZ1- mice are protected from periodontal 
bone loss in relatively acute models using oral gavage with known human 
periodontal pathogens (Burns et aI., 2006). The novelty of these results is that 
they derive from a truly chronic aging model of periodontitis, which takes into 
consideration any cell-intrinsic defects of the immune system and the tissue 
environment in the aged mice. Therefore, this is a step closer towards what may 
occur in elderly humans, and strengthens the case for these molecules as 
therapeutic targets in age-associated periodontitis. 
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Inflammation is a "double-edged sword" in the sense that it can kill 
pathogens when operating as intended, but, in addition to causing tissue 
damage, can actually provide nutrients essential to the persistence of certain 
bacteria (Delima and Van Dyke, 2003), thus counteracting the intended effect. 
Our CFU results give us insights into what may have occurred in this respect. 
The oral anaerobic bacterial load was higher in the TLRZ1- mice compared 
with wild-type controls (Figure 6), indicating that TLR2 signaling improves 
bacterial clearance. Despite the more efficient TLR2-mediated bacterial killing by 
our BALB/c wild-type mice, the collateral damage of the inflammatory response 
still resulted in tissue damage, evidenced by the increased bone loss of these 
wild-types. Perhaps some of these anaerobes are cleared effectively, yet the 
most persistent pathogens are prolonging the ineffective inflammation. 
Surprisingly, the MyD88"1- mice showed the opposite trend from the TLRZ1-
mice. MyD88 deficiency improved bacterial clearance (Figure 10), suggesting 
that other immune pathways may work more effectively in the absence of MyD88 
signaling. Given the vast impact of MyD88 signaling, compensatory up-regulation 
of other immune pathways with bactericidal effects is possible. Perhaps 
activation of the MyD88-independent pathway (Figure 11; see below) is providing 
an effective means of clearing these bacteria, either through an effective low-
grade inflammatory response or some other means. 
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It is also possible that a significant lack of inflammation in the MyDBffl -
mice is starving the bacteria of nutrients required for their growth and 
reprod uction. 
These CFU results may involve differing oral bacterial compositions 
responsible for innate immune activation, as well as their differing resistances to 
the host response; we did not identify these bacterial species, although they were 
all anaerobes. It is possible that these bacterial profiles differed between the 
BALB/c and C57BLl6 mice, perhaps due to their different genetic backgrounds; a 
potential source of error, given the vastly different CFU counts between the 
BALB/c and C57BLl6 wild-type mice. Nevertheless, the pathogens that are 
persistent in the C57BLl6 wild-type mice are triggering the chronic inflammation 
responsible for their increased bone loss. 
For the TLRZ1- mice, the quantitative real-time PCR suggests an overall 
decreased inflammatory response compared to the wild-types (Figure 7). In the 
TLRZ1- mice, mRNA expressions for CD14, TLR1 and TLR6 were all expressed 
at lower levels, consistent with the fact that they all associate with TLR2 for 
inflammatory signaling. MyD88 mRNA was also lower, indicating that TLR2 
signals through MyD88 in the wild-types. IL-1 ~ and RANKL, both bone-resorptive 
cytokines, also expressed lower levels in the TLRZ1- mice. These results support 
an increased inflammatory state in normal BALB/c wild-type mice, and thus the 
increased bone loss. 
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The qPCR results for the MyD88-1- mice also indicated a lower expression 
of IL-1 f3 compared to wild-types (Figure 11). Interestingly, unlike the TLRZ1- mice, 
RANKL was expressed at a higher level in the MyD88-1- mice, indicating perhaps, 
distinct effects of My088 deficiency and TLR2 deficiency on bone-resorptive 
mechanisms. The most obvious trend in these qPCR results, however, is the 
upregulation of the My088-independent pathway in the MyD88-1- mice, as 
evidenced by their increased mRNA expression of TLR4, TRIF, and IFNf3. Thus, 
we can conclude that this pathway does not produce comparable inflammation or 




In conclusion, we have shown that TLR2 and MyD88 contribute to 
periodontal bone loss in aged mice. Although their differential effects on bacterial 
burden and their influence on certain genes (e.g. RANKL) possibly indicate 
distinct bone-resorptive mechanisms, they both induce destructive effects. This 
suggests that these molecules may be potential targets for drug therapies in the 
treatment of age-associated periodontitis. This in turn, may reduce the risk of 
associated conditions in the growing elderly population. 
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